Flynn Daniel Lee 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Flynn Daniel Lee
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-06-16$14.40/sh−1,655$23,835→ 57,158 total
Holdings
- 91,020(indirect: By Trust)
Common Stock
- 180,947(indirect: By Trust)
Common Stock
- 49,488(indirect: By GRAT)
Common Stock
Footnotes (2)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock units.
- [F2]Reflects shares previously transferred from the Daniel L. Flynn Revocable Trust to the Reporting Person's grantor retained annuity trust.